NRIX DCF Valuation - Nurix Therapeutics Inc

Watchlist Manager

Watchlist

Price: 14.76 USD -4.96% Market Closed

Market Cap: $1.5B

	Nurix Therapeutics Inc NASDAQ:NRIX	US
D	Debao Property Development Ltd SGX:BTF	CN
	Vmoto Ltd ASX:VMT	AU
H	Horizonte Minerals PLC TSX:HZM	UK
	Kelso Technologies Inc TSX:KLS	CA
	Ai-Media Technologies Ltd ASX:AIM	AU
	URU Metals Ltd LSE:URU	CA
	Editas Medicine Inc NASDAQ:EDIT	US
I	Isracard Ltd TASE:ISCD	IL
	American Battery Materials Inc OTC:BLTH	US
	Electrovaya Inc TSX:EFL	CA
D	DeA Capital SpA F:CWH	IT
A	Abirami Financial Services (India) Ltd BSE:511756	IN
	Vir Biotechnology Inc NASDAQ:VIR	US
	Silvercrest Asset Management Group Inc NASDAQ:SAMG	US

NRIX's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.